Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2008
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
J K Salama, K M Stenson, E O Kistner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)
A Argiris, J W Lee, J Stevenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2012
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
A Argiris, A P Kotsakis, T Hoang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer
R L Ferris, J L Geiger, S Trivedi, et al.
ESMO Open
|
October 28, 2025
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapy
P Bossi, R Gili, S Calza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2011
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
A Argiris, M V Karamouzis, R Smith, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 16, 2013
A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer
S S Ramalingam, A Kotsakis, A A Tarhini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S J Wong, T Karrison, D N Hayes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2016
Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer
A Argiris, J E Bauman, J Ohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era
A Alberti, C Gurizzan, C Resteghini, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2008
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
J K Salama, K M Stenson, E O Kistner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)
A Argiris, J W Lee, J Stevenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2012
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
A Argiris, A P Kotsakis, T Hoang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer
R L Ferris, J L Geiger, S Trivedi, et al.
ESMO Open
|
October 28, 2025
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapy
P Bossi, R Gili, S Calza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2011
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
A Argiris, M V Karamouzis, R Smith, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 16, 2013
A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer
S S Ramalingam, A Kotsakis, A A Tarhini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S J Wong, T Karrison, D N Hayes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2016
Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer
A Argiris, J E Bauman, J Ohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era
A Alberti, C Gurizzan, C Resteghini, et al.
Page
of 3